Dynavax Technologies
DVAX
$9.82
Share price
2.29%
Change (1 day)
26.55%
Change (1 year)
Categories
Market capitalization of Dynavax Technologies (DVAX)
Market cap: $1.24 Billion
As of May 2022 Dynavax Technologies has a market cap of $1.24 Billion. This makes Dynavax Technologies the world's 4041th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Dynavax Technologies from 2004 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $1.21 B | -28.15% |
| 2021 | $1.68 B | 244.19% |
| 2020 | $0.49 B | 2.21% |
| 2019 | $0.47 B | -16.59% |
| 2018 | $0.57 B | -49.24% |
| 2017 | $1.13 B | 644.59% |
| 2016 | $0.15 B | -83.62% |
| 2015 | $0.92 B | 109.42% |
| 2014 | $0.44 B | -13.89% |
| 2013 | $0.51 B | -1.13% |
| 2012 | $0.52 B | 23.74% |
| 2011 | $0.42 B | 13.8% |
| 2010 | $0.36 B | 379.99% |
| 2009 | $0.07 B | 130.23% |
| 2008 | $0.03 B | -83.52% |
| 2007 | $0.20 B | -44.27% |
| 2006 | $0.36 B | 265.8% |
| 2005 | $0.09 B | -47.38% |
| 2004 | $0.18 B |
End of Day market cap according to different sources
On May 16th, 2022 the market cap of Dynavax Technologies was reported to be:
$1.24 Billion
$1.24 Billion
$1.17 Billion
$1.23 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $284.30 B | 22,820.67% | 🇺🇸 USA |
 Amgen AMGN | $130.27 B | 10,402.83% | 🇺🇸 USA |
 Biogen BIIB | $29.05 B | 2,242.27% | 🇺🇸 USA |
 Gilead Sciences GILD | $78.06 B | 6,193.88% | 🇺🇸 USA |
 Merck MRK | $233.45 B | 18,721.57% | 🇺🇸 USA |
 Astrazeneca AZN | $199.84 B | 16,011.95% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $112.78 B | 8,993.00% | 🇬🇧 UK |
 Agenus
AGEN | $0.42 B | -65.48% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $8.78 B | 608.08% | 🇮🇱 Israel |